Literature DB >> 33972372

Allocation of COVID-19 vaccination: when public prioritisation preferences differ from official regulations.

Philipp Sprengholz1, Lars Korn2,3, Sarah Eitze2,3, Cornelia Betsch2,3.   

Abstract

As vaccines against COVID-19 are scarce, many countries have developed vaccination prioritisation strategies focusing on ethical and epidemiological considerations. However, public acceptance of such strategies should be monitored to ensure successful implementation. In an experiment with N=1379 German participants, we investigated whether the public's vaccination allocation preferences matched the prioritisation strategy approved by the German government. Results revealed different allocations. While the government had top-prioritised vulnerable people (being of high age or accommodated in nursing homes for the elderly), participants preferred exclusive allocation of the first available vaccines to medical staff and personnel caring for the elderly. Interestingly, allocation preferences did not change when participants were told how many individuals were included in each group. As differences between allocation policies and public preferences can affect trust in the government and threaten the social contract between generations, we discuss possible strategies to align vaccination prioritisations. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  COVID-19; public health ethics; resource allocation

Year:  2021        PMID: 33972372     DOI: 10.1136/medethics-2021-107339

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  3 in total

1.  Exploring the roles of trust and social group preference on the legitimacy of algorithmic decision-making vs. human decision-making for allocating COVID-19 vaccinations.

Authors:  Marco Lünich; Kimon Kieslich
Journal:  AI Soc       Date:  2022-04-21

2.  COVID-19 vaccination and drug users: Past, present, and future.

Authors:  Fabio Lugoboni; Luigi Stella; Lorenzo Zamboni; Simone Campagnari; Francesca Fusina; Ernesto De Bernardis
Journal:  J Public Health Res       Date:  2022-08-10

3.  Immunogenicity and safety of the CoronaVac vaccine in patients with cancer receiving active systemic therapy.

Authors:  Cengiz Karacin; Tulay Eren; Esra Zeynelgil; Goksen Inanc Imamoglu; Mustafa Altinbas; Ibrahim Karadag; Fatma Bugdayci Basal; Irem Bilgetekin; Osman Sutcuoglu; Ozan Yazici; Nuriye Ozdemir; Ahmet Ozet; Yesim Yildiz; Selin Akturk Esen; Gokhan Ucar; Dogan Uncu; Bedia Dinc; Musa Baris Aykan; İsmail Erturk; Nuri Karadurmus; Burak Civelek; İsmail Çelik; Yakup Ergun; Mutlu Dogan; Omur Berna Oksuzoglu
Journal:  Future Oncol       Date:  2021-08-03       Impact factor: 3.404

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.